Join Our Webinar: Discover the Future of 3D Tumor Modeling with Tumoroid-on-a-Chip Technology

Don’t Miss Out: Live Webinar on Tumoroid-on-a-Chip – August 22, 12 PM EDT!

Mark your calendar now—August 22, 2025 at 12 PM EDT—for an exclusive live webinar hosted by Creative Biolabs, spotlighting the revolutionary tumoroid-on-a-chip technology for cancer immunotherapy research.

This highly anticipated session, titled “Tumoroid-on-a-Chip as a Physiologically Relevant Model for Immunotherapy,” will be led by Dr. Mohsen Akbari, a leading innovator in microfluidics and tumor microenvironment modeling. If you’re engaged in oncology, immunotherapy, or drug discovery, this is a webinar you can’t afford to miss.

🕛 When?

Live Broadcast: August 22, 2025 | 12:00 PM EDT (Eastern Daylight Time)
Set a reminder and reserve your seat—space is limited!

🔬 What to Expect:

As cancer researchers continue to face challenges in treating solid tumors like glioblastoma, tumoroid-on-a-chip platforms offer new hope. Dr. Akbari’s team has engineered a microfluidic system that replicates the tumor’s native environment—bridging the gap between 2D cell cultures and in vivo models.

Key highlights include:

• Development of high-throughput tumoroid-on-plate systems
• Integration of cellular heterogeneity and ECM structure
• Realistic immunotherapy screening conditions
• Use cases in drug development and translational oncology

This innovative platform mimics human tumor physiology more accurately than traditional methods, making it a valuable tool for testing novel therapies and improving clinical translation.

✅ Why Attend?

Attending this live event gives you direct access to expert insights, practical applications, and emerging trends in 3D tumor modeling. You’ll gain a firsthand look at how Creative Biolabs is driving the future of immunotherapy research with advanced microengineering technologies.

📌 Save the Date: August 22 at 12 PM EDT

👉 Register now to join the webinar and stay ahead in the fight against cancer.

#TumoroidOnAChip #Webinar2025 #CancerResearch #Immunotherapy #CreativeBiolabs #3DTumorModel #DrugDiscovery